Trials / Completed
CompletedNCT02289846
Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Phase 2a Study of Oral IW-9179 Administered Once and Twice Daily for 4 Weeks to Patients With Diabetic Gastroparesis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Ironwood Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study are to evaluate the safety of IW-9179 in patients with diabetic gastroparesis (DGP) and the effect of treatment on the cardinal symptoms of DGP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IW-9179 | |
| DRUG | Matching Placebo |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2014-11-13
- Last updated
- 2016-12-05
Locations
22 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02289846. Inclusion in this directory is not an endorsement.